Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Public Issue
₹ 25.6
₹ 40
150
₹ 6,000.00
Mumbai
27-May-2008
30-May-2008
27-Jun-2008
1 Week | -4.65 |
3 Month | 1.27 |
1 Year | -18.81 |
3 Year | -37.52 |
Public Issue of 64,00,000 equity shares of Rs.10/- each at a price of Rs.40/- per equity share (including share premium of Rs.30/-per equity share) for cash aggregating Rs.25.60 Crores by Bafna Pharmaceuticals Limited (Hereinafter Referred to as the Issue). The issue will constitute 40.05% of the post issue paid-up capital of the company.The issue price is 4 times of the face value
To undertake Brand Buld in Domestic & Intl.Markets. To part Fin the cost of obtaining MHRA Approval. To Set up a Research & Development Unit. Tp Repay of High Cost Debt. To Meet the Working Capital Requirement.
Bafna Pharmaceuticals Ltd, Subramanian Building, 1ST Floor No 1, Club House Road, Chennai - 600002
Phone - 91-44-28462700
Fax - 91-44-28460129
Email - cs@bafnapharma.com, info@bafnapharma.com
Website - www.bafnapharma.com